# US 2024/0390416 A1 · Ophthalmological composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390416 A1
- Document ID: US20240390416A1
- Status: Published application
- Kind: A1
- Application number: 18/695,745
- Filed: 2022-09-30
- Published: 2024-11-28
- Earliest claimed: 2021-09-30
- Assignees: Rohto Pharmaceutical Co., Ltd.
- Applicants: Rohto Pharmaceutical Co., Ltd.
- Inventors: Takuto MORIKAWA; Sachiko MATSUMOTO; Rie MATSUKI
- Web page: https://patentgrep.com/patent/US20240390416A1

## CPC

- A61K 33/30: Zinc; Compounds thereof
- A61P 27/02: Ophthalmic agents
- A61K 9/0048: {Eye, e.g. artificial tears}
- A61K 31/79: Polymers of vinyl pyrrolidone
- A61K 47/32: Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone}
- A61P 27/04: Artificial tears; Irrigation solutions
- A61P 31/04: Antibacterial agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 47/02: Inorganic compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to an ophthalmological composition containing zinc chloride (A) and a polyvinyl-based polymer compound (B).

## Claims

### Claim at position 1

1: An ophthalmological composition comprising:
zinc chloride (A); and
a polyvinyl-based polymer compound (B).

### Claim at position 2 (depends on 1)

2: The ophthalmological composition according to claim 1,
wherein the polyvinyl-based polymer compound (B) is polyvinyl pyrrolidone.

### Claim at position 3 (depends on 2)

3: The ophthalmological composition according to claim 2,
wherein a content of the polyvinyl pyrrolidone is 0.001 to 5 w/v % based on a total amount of the ophthalmological composition.

### Claim at position 4 (depends on 2)

4: The ophthalmological composition according to claim 2,
wherein the polyvinyl pyrrolidone has a viscosity characteristic value of 10 to 150.

### Claim at position 5 (depends on 1)

5: The ophthalmological composition according to claim 1 that is for suppressing eye dryness or dry eye.
